The artificial pancreas (AP) system is designed to regulate blood glucose in subjects with type 1 diabetes using a continuous glucose monitor informed controller that adjusts insulin infusion via an insulin pump. However, current AP developments are mainly hybrid closed-loop systems that include feed-forward actions triggered by the announcement of meals or exercise. The first step to fully closing the loop in the AP requires removing meal announcement, which is currently the most effective way to alleviate postprandial hyperglycemia due to the delay in insulin action. Here, a novel approach to meal detection in the AP is presented using a sliding window and computing the normalized cross-covariance between measured glucose and the forward ...
Continuous Glucose Monitoring (CGM) sensors are key components in an artificial pancreas, an emergin...
© 2021 IEEE. Personal use of this material is permitted. Permissíon from IEEE must be obtained for a...
The first attempts for automated glucose control were made in the seventies of the last century. Now...
The artificial pancreas (AP) system is designed to regulate blood glucose in subjects with type 1 di...
The artificial pancreas (AP) system is designed to regulate blood glucose in subjects with type 1 di...
Background: Either under standard basal-bolus treatment or hybrid closed-loop control, subjects with...
Current glucose control systems automatically regulate basal insulin infusion, but users still need ...
Current artificial pancreas (AP) systems are hybrid closed-loop systems that require manual meal ann...
Maintaining good glycemic control is a continuous challenge for type-1 diabetic patients. The curren...
Blood glucose management systems are an important class of Medical Cyber-Physical Systems that provi...
Meals are one of the greatest challenges to glucose regulation in diabetes mellitus type 1. Several ...
International audienceThis study aims at developing an unannounced meal detection method for artific...
Accurate continuous glucose monitoring (CGM) is essential for fully automated glucose control in dia...
Continuous Subcutaneous Insulin Infusion (CSII) pumps are essential components in a closed-loop insu...
Background and objective: Hybrid automated insulin delivery systems rely on carbohydrate counting to...
Continuous Glucose Monitoring (CGM) sensors are key components in an artificial pancreas, an emergin...
© 2021 IEEE. Personal use of this material is permitted. Permissíon from IEEE must be obtained for a...
The first attempts for automated glucose control were made in the seventies of the last century. Now...
The artificial pancreas (AP) system is designed to regulate blood glucose in subjects with type 1 di...
The artificial pancreas (AP) system is designed to regulate blood glucose in subjects with type 1 di...
Background: Either under standard basal-bolus treatment or hybrid closed-loop control, subjects with...
Current glucose control systems automatically regulate basal insulin infusion, but users still need ...
Current artificial pancreas (AP) systems are hybrid closed-loop systems that require manual meal ann...
Maintaining good glycemic control is a continuous challenge for type-1 diabetic patients. The curren...
Blood glucose management systems are an important class of Medical Cyber-Physical Systems that provi...
Meals are one of the greatest challenges to glucose regulation in diabetes mellitus type 1. Several ...
International audienceThis study aims at developing an unannounced meal detection method for artific...
Accurate continuous glucose monitoring (CGM) is essential for fully automated glucose control in dia...
Continuous Subcutaneous Insulin Infusion (CSII) pumps are essential components in a closed-loop insu...
Background and objective: Hybrid automated insulin delivery systems rely on carbohydrate counting to...
Continuous Glucose Monitoring (CGM) sensors are key components in an artificial pancreas, an emergin...
© 2021 IEEE. Personal use of this material is permitted. Permissíon from IEEE must be obtained for a...
The first attempts for automated glucose control were made in the seventies of the last century. Now...